Suven Life Sciences

215.75

-18.60 (-7.94%) tick

BSE

Buy Sell

NSE BSE

Last updated on 6 Jun 2025 12:53 PM

Open Demat account

Returns

-12.26%

Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

5110.56

Earning Per Share

-0.37

Dividend Yield

P/E Ratio

P/B Ratio

6.39

Debt to Equity

Performance

min-value

max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value

max-value

5.34% down side

up side5.34%

About the company

Suven Life Sciences Limited (Formerly known as Suven Pharmaceuticals Ltd) was incorporated in March, 1989. The Company changed its name from Suven Pharmaceuticals Limited to Suven Life Sciences Limit... ted in September, 2003. Promoted by Sudharani Jasti and Venkateswarlu Jasti, the Company began operations in 1989 as specialty chemicals provider. The Company is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders. Suven has a wholly owned subsidiary, Suven Neurosciences, Inc., USA, focused on clinical development activities of Suven molecules from phase 2, Proof-of-Concept (POC) studies. Show more

Similar Companies

GMR Airports Infrastructure

85.72 +0.81 (0.01%) tick

1Yr Returns

+0.72%

JSW Infrastructure

304.3 -2.80 (-0.01%) tick

1Yr Returns

+7.64%

CDSL

1791.2 +12.40 (0.01%) tick

1Yr Returns

+74.88%

Multi Commodity Exchange

7460 +361.00 (0.05%) tick

1Yr Returns

+103.71%

Aegis Vopak Terminals

(%) tick

1Yr Returns

+7.5%